REFERENCES
1. Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16:203-12.
2. Mishra S, Kass DA. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2021;18:400-23.
4. Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res. 2016;118:1808-29.
5. Zhang M, Liu Q, Meng H, et al. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9:12.
6. Vargas JNS, Hamasaki M, Kawabata T, Youle RJ, Yoshimori T. The mechanisms and roles of selective autophagy in mammals. Nat Rev Mol Cell Biol. 2023;24:167-85.
7. Li W, He P, Huang Y, et al. Selective autophagy of intracellular organelles: recent research advances. Theranostics. 2021;11:222-56.
8. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221:3-12.
9. Wu MY, Li ZW, Lu JH. Molecular modulators and receptors of selective autophagy: disease implication and identification strategies. Int J Biol Sci. 2024;20:751-64.
10. Yao RQ, Ren C, Xia ZF, Yao YM. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. Autophagy. 2021;17:385-401.
11. Bjørkøy G, Lamark T, Brech A, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 2005;171:603-14.
12. Kirkin V, Lamark T, Sou YS, et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell. 2009;33:505-16.
13. Wild P, Farhan H, McEwan DG, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333:228-33.
14. Tumbarello DA, Manna PT, Allen M, et al. The autophagy receptor TAX1BP1 and the molecular motor myosin VI are required for clearance of salmonella typhimurium by autophagy. PLoS Pathog. 2015;11:e1005174.
15. Li A, Gao M, Liu B, et al. Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease. Cell Death Dis. 2022;13:444.
16. Diao RY, Gustafsson ÅB. Mitochondrial quality surveillance: mitophagy in cardiovascular health and disease. Am J Physiol Cell Physiol. 2022;322:C218-30.
17. Kim S, Kim N, Park S, et al. Tanycytic TSPO inhibition induces lipophagy to regulate lipid metabolism and improve energy balance. Autophagy. 2020;16:1200-20.
18. Minami S, Yamamoto T, Takabatake Y, et al. Lipophagy maintains energy homeostasis in the kidney proximal tubule during prolonged starvation. Autophagy. 2017;13:1629-47.
19. Singh R, Kaushik S, Wang Y, et al. Autophagy regulates lipid metabolism. Nature. 2009;458:1131-5.
20. Ajoolabady A, Wang S, Kroemer G, et al. ER stress in cardiometabolic diseases: from molecular mechanisms to therapeutics. Endocr Rev. 2021;42:839-71.
21. Bernales S, Schuck S, Walter P. ER-phagy: selective autophagy of the endoplasmic reticulum. Autophagy. 2007;3:285-7.
22. Sahu R, Kaushik S, Clement CC, et al. Microautophagy of cytosolic proteins by late endosomes. Dev Cell. 2011;20:131-9.
23. Madrigal-Matute J, de Bruijn J, van Kuijk K, et al. Protective role of chaperone-mediated autophagy against atherosclerosis. Proc Natl Acad Sci USA. 2022;119:e2121133119.
24. Subramani J, Kundumani-Sridharan V, Das KC. Chaperone-mediated autophagy of eNOS in myocardial ischemia-reperfusion injury. Circ Res. 2021;129:930-45.
25. Ghosh R, Gillaspie JJ, Campbell KS, Symons JD, Boudina S, Pattison JS. Chaperone-mediated autophagy protects cardiomyocytes against hypoxic-cell death. Am J Physiol Cell Physiol. 2022;323:C1555-75.
26. Mialet-Perez J, Vindis C. Autophagy in health and disease: focus on the cardiovascular system. Essays Biochem. 2017;61:721-32.
28. Wang S, Long H, Hou L, et al. The mitophagy pathway and its implications in human diseases. Signal Transduct Target Ther. 2023;8:304.
29. Lu Y, Li Z, Zhang S, Zhang T, Liu Y, Zhang L. Cellular mitophagy: mechanism, roles in diseases and small molecule pharmacological regulation. Theranostics. 2023;13:736-66.
30. Ajoolabady A, Chiong M, Lavandero S, Klionsky DJ, Ren J. Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment. Trends Mol Med. 2022;28:836-49.
31. Lampert MA, Orogo AM, Najor RH, et al. BNIP3L/NIX and FUNDC1-mediated mitophagy is required for mitochondrial network remodeling during cardiac progenitor cell differentiation. Autophagy. 2019;15:1182-98.
32. Terešak P, Lapao A, Subic N, Boya P, Elazar Z, Simonsen A. Regulation of PRKN-independent mitophagy. Autophagy. 2022;18:24-39.
33. Schubert AF, Gladkova C, Pardon E, et al. Structure of PINK1 in complex with its substrate ubiquitin. Nature. 2017;552:51-6.
34. Riley BE, Lougheed JC, Callaway K, et al. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat Commun. 2013;4:1982.
35. Narendra DP, Jin SM, Tanaka A, et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010;8:e1000298.
36. Ordureau A, Heo JM, Duda DM, et al. Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy. Proc Natl Acad Sci USA. 2015;112:6637-42.
37. Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, Randow F. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol. 2009;10:1215-21.
38. Sun Y, Cao Y, Wan H, et al. A mitophagy sensor PPTC7 controls BNIP3 and NIX degradation to regulate mitochondrial mass. Mol Cell. 2024;84:327-44.e9.
39. Liu L, Feng D, Chen G, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 2012;14:177-85.
40. Murakawa T, Yamaguchi O, Hashimoto A, et al. Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation. Nat Commun. 2015;6:7527.
41. Bhujabal Z, Birgisdottir ÅB, Sjøttem E, et al. FKBP8 recruits LC3A to mediate Parkin-independent mitophagy. EMBO Rep. 2017;18:947-61.
42. Chu CT, Ji J, Dagda RK, et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol. 2013;15:1197-205.
43. Strappazzon F, Nazio F, Corrado M, et al. AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1. Cell Death Differ. 2015;22:419-32.
44. Dhingra R, Rabinovich-Nikitin I, Kirshenbaum LA. Ulk1/Rab9-mediated alternative mitophagy confers cardioprotection during energy stress. J Clin Invest. 2019;129:509-12.
45. Soubannier V, McLelland GL, Zunino R, et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr Biol. 2012;22:135-41.
47. Qiu Z, Wei Y, Song Q, et al. The role of myocardial mitochondrial quality control in heart failure. Front Pharmacol. 2019;10:1404.
48. Billia F, Hauck L, Konecny F, Rao V, Shen J, Mak TW. PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci USA. 2011;108:9572-7.
49. Sun T, Han Y, Li JL, et al. FOXO3a-dependent PARKIN negatively regulates cardiac hypertrophy by restoring mitophagy. Cell Biosci. 2022;12:204.
50. Wang B, Nie J, Wu L, et al. AMPKα2 protects against the development of heart failure by enhancing mitophagy via PINK1 phosphorylation. Circ Res. 2018;122:712-29.
51. Tan Y, Li M, Wu G, et al. Short-term but not long-term high fat diet feeding protects against pressure overload-induced heart failure through activation of mitophagy. Life Sci. 2021;272:119242.
52. Shao D, Kolwicz SC Jr, Wang P, et al. Increasing fatty acid oxidation prevents high-fat diet-induced cardiomyopathy through regulating parkin-mediated mitophagy. Circulation. 2020;142:983-97.
53. Fu J, Su C, Ge Y, et al. PDE4D inhibition ameliorates cardiac hypertrophy and heart failure by activating mitophagy. Redox Biol. 2025;81:103563.
54. Abudureyimu M, Zhao L, Luo X, Wang X, Liu H. Influences of ALDH2 on cardiomyocyte apoptosis in heart failure rats through regulating PINK1-parkin signaling pathway-mediated mitophagy. Cell Mol Biol. 2022;68:94-102.
55. Sonn SK, Song EJ, Seo S, et al. Peroxiredoxin 3 deficiency induces cardiac hypertrophy and dysfunction by impaired mitochondrial quality control. Redox Biol. 2022;51:102275.
56. Zhang H, Xu T, Mei X, et al. PINK1 modulates Prdx2 to reduce lipotoxicity-induced apoptosis and attenuate cardiac dysfunction in heart failure mice with a preserved ejection fraction. Clin Transl Med. 2025;15:e70166.
57. Zhou H, Wang X, Xu T, et al. PINK1-mediated mitophagy attenuates pathological cardiac hypertrophy by suppressing the mtDNA release-activated cGAS-STING pathway. Cardiovasc Res. 2025;121:128-42.
58. Zhou G, Wang X, Guo M, et al. Mitophagy deficiency activates stimulator of interferon genes activation and aggravates pathogenetic cardiac remodeling. Genes Dis. 2024;11:101074.
59. Chaanine AH, Jeong D, Liang L, et al. JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure. Cell Death Dis. 2012;3:265.
60. Svagusa T, Sikiric S, Milavic M, et al. Heart failure in patients is associated with downregulation of mitochondrial quality control genes. Eur J Clin Invest. 2023;53:e14054.
61. Borlak J, Ciribilli Y, Bisio A, et al. The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes. J Transl Med. 2024;22:845.
62. Dhingra R, Margulets V, Chowdhury SR, et al. Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling. Proc Natl Acad Sci USA. 2014;111:E5537-44.
63. Wu W, Lin C, Wu K, et al. FUNDC1 regulates mitochondrial dynamics at the ER-mitochondrial contact site under hypoxic conditions. EMBO J. 2016;35:1368-84.
64. Chen G, Han Z, Feng D, et al. A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy. Mol Cell. 2014;54:362-77.
65. Wu W, Tian W, Hu Z, et al. ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy. EMBO Rep. 2014;15:566-75.
66. Liu H, Zang C, Yuan F, et al. The role of FUNDC1 in mitophagy, mitochondrial dynamics and human diseases. Biochem Pharmacol. 2022;197:114891.
67. Wu S, Lu Q, Wang Q, et al. Binding of FUN14 domain containing 1 with inositol 1,4,5-trisphosphate receptor in mitochondria-associated endoplasmic reticulum membranes maintains mitochondrial dynamics and function in hearts in vivo. Circulation. 2017;136:2248-66.
68. Liu R, Xu C, Zhang W, et al. FUNDC1-mediated mitophagy and HIF1α activation drives pulmonary hypertension during hypoxia. Cell Death Dis. 2022;13:634.
69. Li J, Li H, Niu N, Zhu Y, Hou S, Zhao W. NRF-1 promotes FUNDC1-mediated mitophagy as a protective mechanism against hypoxia-induced injury in cardiomyocytes. Exp Cell Res. 2025;446:114472.
70. Liu J, Curtin C, Lall R, et al. Inhibition of cyp1a protects mice against anthracycline cardiomyopathy. bioRxiv. 2024.
71. Wang J, Wang X, Du W, et al. BI-1 ameliorates myocardial injury by activating the mitochondrial unfolded protein response and FUNDC1-related mitophagy in cardiorenal syndrome type 3. Cell Signal. 2022;91:110218.
72. Li FJ, Hu H, Wu L, et al. Ablation of mitophagy receptor FUNDC1 accentuates septic cardiomyopathy through ACSL4-dependent regulation of ferroptosis and mitochondrial integrity. Free Radic Biol Med. 2024;225:75-86.
73. Wang W, Li E, Zou J, et al. Ubiquitin ligase RBX2/SAG regulates mitochondrial ubiquitination and mitophagy. Circ Res. 2024;135:e39-56.
74. Wang W, Liu J, Li J, Su H. A PRKN-independent mechanism regulating cardiac mitochondrial quality control. Autophagy. 2025;21:254-6.
75. Zhang S, Yan F, Luan F, et al. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury. Phytomedicine. 2024;129:155649.
76. Yu JD, Miyamoto S. Molecular signaling to preserve mitochondrial integrity against ischemic stress in the heart: rescue or remove mitochondria in danger. Cells. 2021;10:3330.
77. Feng Y, Madungwe NB, da Cruz Junho CV, Bopassa JC. Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy. Br J Pharmacol. 2017;174:4329-44.
78. Wang L, Li Q, Diao J, Lin L, Wei J. MiR-23a is involved in myocardial ischemia/reperfusion injury by directly targeting CX43 and regulating mitophagy. Inflammation. 2021;44:1581-91.
79. Xu Q, Liu S, Gong Q, et al. Notch1 protects against ischemic-reperfusion injury by suppressing PTEN-Pink1-mediated mitochondrial dysfunction and mitophagy. Cells. 2022;12:137.
80. Hu J, Liu T, Fu F, et al. Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy. J Transl Med. 2022;20:447.
81. Tu M, Tan VP, Yu JD, et al. RhoA signaling increases mitophagy and protects cardiomyocytes against ischemia by stabilizing PINK1 protein and recruiting Parkin to mitochondria. Cell Death Differ. 2022;29:2472-86.
82. Xu C, Cao Y, Liu R, et al. Mitophagy-regulated mitochondrial health strongly protects the heart against cardiac dysfunction after acute myocardial infarction. J Cell Mol Med. 2022;26:1315-26.
83. Ji H, Wang J, Muid D, Song W, Jiang Y, Zhou H. FUNDC1 activates the mitochondrial unfolded protein response to preserve mitochondrial quality control in cardiac ischemia/reperfusion injury. Cell Signal. 2022;92:110249.
84. Yan Y, Tian LY, Jia Q, et al. MiR-130a-3p regulates FUNDC1-mediated mitophagy by targeting GJA1 in myocardial ischemia/reperfusion injury. Cell Death Discov. 2023;9:77.
85. Mao S, Tian S, Luo X, Zhou M, Cao Z, Li J. Overexpression of PLK1 relieved the myocardial ischemia-reperfusion injury of rats through inducing the mitophagy and regulating the p-AMPK/FUNDC1 axis. Bioengineered. 2021;12:2676-87.
86. Cai W, Xu D, Zeng C, et al. Modulating lysine crotonylation in cardiomyocytes improves myocardial outcomes. Circ Res. 2022;131:456-72.
87. Cai X, Zou P, Hong L, et al. RNA methylation reading protein YTHDF2 relieves myocardial ischemia-reperfusion injury by downregulating BNIP3 via m6A modification. Hum Cell. 2023;36:1948-64.
88. Zhang YN, Pang YX, Liu DW, Hu HJ, Xie RQ, Cui W. JMJD5 attenuates oxygen-glucose deprivation and reperfusion-induced injury in cardiomyocytes through regulation of HIF-1α-BNIP3. Kaohsiung J Med Sci. 2022;38:38-48.
89. Cheng N, Wang MY, Wu YB, et al. Circular RNA POSTN promotes myocardial infarction-induced myocardial injury and cardiac remodeling by regulating miR-96-5p/BNIP3 Axis. Front Cell Dev Biol. 2020;8:618574.
90. Moyzis AG, Lally NS, Liang W, Najor RH, Gustafsson ÅB. Mcl-1 differentially regulates autophagy in response to changes in energy status and mitochondrial damage. Cells. 2022;11:1469.
91. Huang G, Lu X, Duan Z, et al. PCSK9 knockdown can improve myocardial ischemia/reperfusion injury by inhibiting autophagy. Cardiovasc Toxicol. 2022;22:951-61.
92. Xu J, Kitada M, Ogura Y, Koya D. Relationship between autophagy and metabolic syndrome characteristics in the pathogenesis of atherosclerosis. Front Cell Dev Biol. 2021;9:641852.
93. Poznyak AV, Nikiforov NG, Wu WK, Kirichenko TV, Orekhov AN. Autophagy and mitophagy as essential components of atherosclerosis. Cells. 2021;10:443.
94. Lee J, Yoo JH, Kim HS, et al. C1q/TNF-related protein-9 attenuates palmitic acid-induced endothelial cell senescence via increasing autophagy. Mol Cell Endocrinol. 2021;521:111114.
95. Profumo E, Maggi E, Arese M, et al. Neuropeptide Y promotes human M2 macrophage polarization and enhances p62/SQSTM1-dependent autophagy and NRF2 activation. Int J Mol Sci. 2022;23:13009.
96. Kim S, Lee W, Cho K. P62 links the autophagy pathway and the ubiquitin-proteasome system in endothelial cells during atherosclerosis. Int J Mol Sci. 2021;22:7791.
97. Mu J, Zhang D, Tian Y, Xie Z, Zou MH. BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1/Parkin-mediated mitophagy in vivo. J Mol Cell Cardiol. 2020;149:1-14.
98. Yang N, Zhang R, Zhang H, Yu Y, Xu Z. ZIP7 contributes to the pathogenesis of diabetic cardiomyopathy by suppressing mitophagy in mouse hearts. Cardiovasc Diabetol. 2024;23:399.
99. Ham SY, Nam SB, Kwak YL, Kim TL, Park JK, Shim YH. Age-related difference in the effect of acute hyperglycemia on myocardial ischemia-reperfusion injury. J Gerontol A Biol Sci Med Sci. 2020;75:425-31.
100. Zhang Y, Zou R, Abudureyimu M, et al. Mitochondrial aldehyde dehydrogenase rescues against diabetic cardiomyopathy through GSK3β-mediated preservation of mitochondrial integrity and Parkin-mediated mitophagy. J Mol Cell Biol. 2024;15:mjad056.
101. Schott MB, Rozeveld CN, Weller SG, McNiven MA. Lipophagy at a glance. J Cell Sci. 2022;135:jcs259402.
102. Robichaud S, Fairman G, Vijithakumar V, et al. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells. Autophagy. 2021;17:3671-89.
103. Pu M, Zheng W, Zhang H, et al. ORP8 acts as a lipophagy receptor to mediate lipid droplet turnover. Protein Cell. 2023;14:653-67.
105. Wirth M, Joachim J, Tooze SA. Autophagosome formation-the role of ULK1 and Beclin1-PI3KC3 complexes in setting the stage. Semin Cancer Biol. 2013;23:301-9.
106. Huang Y, Luo G, Peng K, et al. Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity. J Cell Biol. 2024;223:e202308099.
107. Geng F, Guo D. SREBF1/SREBP-1 concurrently regulates lipid synthesis and lipophagy to maintain lipid homeostasis and tumor growth. Autophagy. 2024;20:1183-5.
108. Shen C, Liu J, Liu H, et al. Timosaponin AIII induces lipid peroxidation and ferroptosis by enhancing Rab7-mediated lipophagy in colorectal cancer cells. Phytomedicine. 2024;122:155079.
109. Du J, Ji X, Xu B, et al. Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease. Metabolism. 2024;152:155769.
110. Wang T, Cheng Z, Zhao R, et al. Sirt6 enhances macrophage lipophagy and improves lipid metabolism disorder by regulating the Wnt1/β-catenin pathway in atherosclerosis. Lipids Health Dis. 2023;22:156.
111. Li Q, Zhao Y, Guo H, et al. Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment. Autophagy. 2023;19:2639-56.
113. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13:709-21.
114. Jeong SJ, Lee MN, Oh GT. The role of macrophage lipophagy in reverse cholesterol transport. Endocrinol Metab. 2017;32:41-6.
115. Puig N, Montolio L, Camps-Renom P, et al. Electronegative LDL promotes inflammation and triglyceride accumulation in macrophages. Cells. 2020;9:583.
116. Jeong SJ, Kim S, Park JG, et al. Prdx1 (peroxiredoxin 1) deficiency reduces cholesterol efflux via impaired macrophage lipophagic flux. Autophagy. 2018;14:120-33.
117. Ouimet M, Ediriweera H, Afonso MS, et al. microRNA-33 regulates macrophage autophagy in atherosclerosis. Arterioscler Thromb Vasc Biol. 2017;37:1058-67.
118. Wang YM, Tang H, Tang YJ, et al. ASIC1/RIP1 accelerates atherosclerosis via disrupting lipophagy. J Adv Res. 2024;63:195-206.
119. Qiao L, Wang HF, Xiang L, et al. Deficient chaperone-mediated autophagy promotes lipid accumulation in macrophage. J Cardiovasc Transl Res. 2021;14:661-9.
120. Gimbrone MA Jr, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118:620-36.
121. Baumer Y, McCurdy S, Weatherby TM, et al. Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat Commun. 2017;8:1129.
122. Torisu K, Singh KK, Torisu T, et al. Intact endothelial autophagy is required to maintain vascular lipid homeostasis. Aging Cell. 2016;15:187-91.
123. Zhang CP, Ding XX, Tian T, et al. Impaired lipophagy in endothelial cells with prolonged exposure to oxidized low‑density lipoprotein. Mol Med Rep. 2020;22:2665-72.
124. Pi H, Wang Z, Liu M, et al. SCD1 activation impedes foam cell formation by inducing lipophagy in oxLDL-treated human vascular smooth muscle cells. J Cell Mol Med. 2019;23:5259-69.
125. Ding Z, Wang X, Schnackenberg L, et al. Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g. Int J Cardiol. 2013;168:1378-85.
126. Lin J, Wang X, Gu M, et al. Geniposide ameliorates atherosclerosis by restoring lipophagy via suppressing PARP1/PI3K/AKT signaling pathway. Phytomedicine. 2024;129:155617.
127. Li BH, Yin YW, Liu Y, et al. TRPV1 activation impedes foam cell formation by inducing autophagy in oxLDL-treated vascular smooth muscle cells. Cell Death Dis. 2014;5:e1182.
128. Chen W, Jin T, Xie Y, et al. Berberine partially ameliorates cardiolipotoxicity in diabetic cardiomyopathy by modulating SIRT3-mediated lipophagy to remodel lipid droplets homeostasis. Br J Pharmacol. 2025;182:5038-56.
129. Ke J, Pan J, Lin H, et al. Targeting Rab7-rilp mediated microlipophagy alleviates lipid toxicity in diabetic cardiomyopathy. Adv Sci. 2024;11:e2401676.
130. Schwarz DS, Blower MD. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci. 2016;73:79-94.
131. Bernales S, McDonald KL, Walter P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol. 2006;4:e423.
133. Chino H, Mizushima N. ER-phagy: quality control and turnover of endoplasmic reticulum. Trends Cell Biol. 2020;30:384-98.
134. Reggio A, Buonomo V, Berkane R, et al. Role of FAM134 paralogues in endoplasmic reticulum remodeling, ER-phagy, and Collagen quality control. EMBO Rep. 2021;22:e52289.
135. Khaminets A, Heinrich T, Mari M, et al. Regulation of endoplasmic reticulum turnover by selective autophagy. Nature. 2015;522:354-8.
136. Ji CH, Kim HY, Heo AJ, et al. The N-degron pathway mediates ER-phagy. Mol Cell. 2019;75:1058-72.e9.
137. Fumagalli F, Noack J, Bergmann TJ, et al. Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery. Nat Cell Biol. 2016;18:1173-84.
138. Grumati P, Morozzi G, Hölper S, et al. Full length RTN3 regulates turnover of tubular endoplasmic reticulum via selective autophagy. Elife. 2017;6:e25555.
139. Smith MD, Harley ME, Kemp AJ, et al. CCPG1 is a non-canonical autophagy cargo receptor essential for ER-phagy and pancreatic ER proteostasis. Dev Cell. 2018;44:217-32.e11.
140. Chen Q, Xiao Y, Chai P, Zheng P, Teng J, Chen J. ATL3 is a tubular ER-phagy receptor for GABARAP-mediated selective autophagy. Curr Biol. 2019;29:846-55.e6.
141. An H, Ordureau A, Paulo JA, Shoemaker CJ, Denic V, Harper JW. TEX264 is an endoplasmic reticulum-resident ATG8-interacting protein critical for ER remodeling during nutrient stress. Mol Cell. 2019;74:891-908.e10.
142. Nthiga TM, Kumar Shrestha B, Sjøttem E, et al. CALCOCO1 acts with VAMP-associated proteins to mediate ER-phagy. EMBO J. 2020;39:e103649.
143. Ishimura R, El-Gowily AH, Noshiro D, et al. The UFM1 system regulates ER-phagy through the ufmylation of CYB5R3. Nat Commun. 2022;13:7857.
144. Liu J, Wu Y, Meng S, et al. Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives. Mol Cancer. 2024;23:22.
145. Zhu L, Wang X, Wang Y. Roles of FAM134B in diseases from the perspectives of organelle membrane morphogenesis and cellular homeostasis. J Cell Physiol. 2021;236:7242-55.
146. Reggiori F, Molinari M. ER-phagy: mechanisms, regulation, and diseases connected to the lysosomal clearance of the endoplasmic reticulum. Physiol Rev. 2022;102:1393-448.
147. Yang Y, Zhang K, Huang S, et al. Apelin-13/APJ induces cardiomyocyte hypertrophy by activating the Pannexin-1/P2X7 axis and FAM134B-dependent reticulophagy. J Cell Physiol. 2022;237:2230-48.
148. Li R, Zhang J, Ji S, et al. Qingre Huoxue decoction attenuates myocardial ischemia-reperfusion injury by regulating the autophagy-endoplasmic reticulum stress axis via FAM134B-mediated ER-phagy. Front Pharmacol. 2024;15:1447610.
149. Qi B, Li T, Luo H, et al. Reticulon 3 deficiency ameliorates post-myocardial infarction heart failure by alleviating mitochondrial dysfunction and inflammation. MedComm. 2024;5:e503.
150. Lacy SM, Taubitz RJ, Urban ND, et al. FICD deficiency protects mice from hypertrophy-induced heart failure via BiP-mediated activation of the UPR (ER) and ER-phagy. bioRxiv. 2024.
151. Li T, Chen Y, Li Y, Yao Z, Liu W. FAM134B-mediated endoplasmic reticulum autophagy protects against sepsis myocardial injury in mice. Aging. 2021;13:13535-47.
152. Keles U, Iscan E, Yilmaz HE, et al. Differential expression of full-length and NH2 terminally truncated FAM134B isoforms in normal physiology and cancer. Am J Physiol Gastrointest Liver Physiol. 2020;319:G733-47.
153. Rani MR, Salin Raj P, Nair A, Ranjith S, Rajankutty K, Raghu KG. In vitro and in vivo studies reveal the beneficial effects of chlorogenic acid against ER stress mediated ER-phagy and associated apoptosis in the heart of diabetic rat. Chem Biol Interact. 2022;351:109755.
154. Jia H, Song Y, Hua Y, Li K, Li S, Wang Y. Molecular mechanism of aerobic exercise ameliorating myocardial mitochondrial injury in mice with heart failure. Int J Mol Sci. 2025;26:2136.
155. Guo C, Wu RY, Dou JH, et al. Mitophagy-dependent cardioprotection of resistance training on heart failure. J Appl Physiol. 2023;135:1390-401.
156. Li H, Qin S, Liang Q, et al. Exercise training enhances myocardial mitophagy and improves cardiac function via Irisin/FNDC5-PINK1/parkin pathway in MI mice. Biomedicines. 2021;9:701.
157. Guo C, Chen MJ, Zhao JR, et al. Exercise training improves cardiac function and regulates myocardial mitophagy differently in ischaemic and pressure-overload heart failure mice. Exp Physiol. 2022;107:562-74.
158. Chen W, Ma M, Song Y, et al. Exercise attenuates myocardial ischemia-reperfusion injury by regulating endoplasmic reticulum stress and mitophagy through M2 acetylcholine receptor. Antioxid Redox Signal. 2024;40:209-21.
159. Gong S, Sui Y, Xiao M, et al. Canagliflozin mediates mitophagy through the AMPK/PINK1/parkin pathway to alleviate ISO-induced cardiac remodeling. J Cardiovasc Pharmacol. 2024;84:496-505.
160. Yang C, Xiao C, Ding Z, Zhai X, Liu J, Yu M. Canagliflozin mitigates diabetic cardiomyopathy through enhanced PINK1-parkin mitophagy. Int J Mol Sci. 2024;25:7008.
161. Cai C, Guo Z, Chang X, et al. Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway. Redox Biol. 2022;52:102288.
162. Song Y, Huang C, Sin J, et al. Attenuation of adverse postinfarction left ventricular remodeling with empagliflozin enhances mitochondria-linked cellular energetics and mitochondrial biogenesis. Int J Mol Sci. 2021;23:437.
163. Zheng Y, Wei W, Wang Y, Li T, Wei Y, Gao S. Gypenosides exert cardioprotective effects by promoting mitophagy and activating PI3K/Akt/GSK-3β/Mcl-1 signaling. PeerJ. 2024;12:e17538.
164. Guo X, Chen Z, Liu Y, et al. 20S-O-Glc-DM treats left ventricular diastolic dysfunction by modulating cardiomyocyte mitochondrial quality and excess autophagy. Phytomedicine. 2024;133:155911.
165. Wang X, Ling G, Wei Y, et al. Activation of ULK1 to trigger FUNDC1-mediated mitophagy in heart failure: effect of Ginsenoside Rg3 intervention. Phytomedicine. 2023;120:155042.
166. Abudureyimu M, Yu W, Cao RY, Zhang Y, Liu H, Zheng H. Berberine promotes cardiac function by upregulating PINK1/parkin-mediated mitophagy in heart failure. Front Physiol. 2020;11:565751.
167. Chen Z, Zhang M, Xu Q, et al. Huangqi-Danshen decoction improves heart failure by regulating pericardial adipose tissue derived extracellular vesicular miR-27a-3p to activate AMPKα2 mediated mitophagy. Phytomedicine. 2024;135:156187.
168. Guan Z, Chen J, Wang L, et al. Nuanxinkang prevents the development of myocardial infarction-induced chronic heart failure by promoting PINK1/Parkin-mediated mitophagy. Phytomedicine. 2023;108:154494.
169. Chen H, Lin Q, Zeng Y, et al. Xinyin tablets affect mitophagy and cardiomyocyte apoptosis to alleviate chronic heart failure by regulating histone deacetylase 3(HDAC3)-mediated PTEN induced putative kinase 1(PINK1)/Parkin signaling pathway. J Ethnopharmacol. 2025;346:119666.
170. Hsieh CC, Li CY, Hsu CH, et al. Mitochondrial protection by simvastatin against angiotensin II-mediated heart failure. Br J Pharmacol. 2019;176:3791-804.
171. Liu W, Zou X, Zheng Y, et al. Aconiti lateralis radix praeparata ameliorates heart failure via PI3K/AKT/Bnip3 pathway. Front Pharmacol. 2025;16:1526653.
172. Li L, Nie S, Wang B, et al. Shenfuyixin Granules enhance mitochondrial autophagy after myocardial infarction by regulating protein deacetylation via the SIRT3/FOXO1 signaling axis. Phytomedicine. 2025;139:156503.
173. Zheng D, Chen L, Li G, et al. Fucoxanthin ameliorated myocardial fibrosis in STZ-induced diabetic rats and cell hypertrophy in HG-induced H9c2 cells by alleviating oxidative stress and restoring mitophagy. Food Funct. 2022;13:9559-75.
174. Li W, Yin L, Sun X, et al. Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling. Cell Death Dis. 2020;11:599.
175. Wang X, Jiang Y, Zhang Y, et al. The roles of the mitophagy inducer Danqi pill in heart failure: A new therapeutic target to preserve energy metabolism. Phytomedicine. 2022;99:154009.
176. Dong X, Zhuang HW, Wen RJ, et al. Xinyang tablet alleviated cardiac dysfunction in a cardiac pressure overload model by regulating the receptor-interacting serum/three-protein kinase 3/FUN14 domain containing 1-mediated mitochondrial unfolded protein response and mitophagy. J Ethnopharmacol. 2024;330:118152.
177. Xia R, Wang W, Gao B, et al. Moxibustion alleviates chronic heart failure by regulating mitochondrial dynamics and inhibiting autophagy. Exp Ther Med. 2022;23:359.
178. Xiao Y, Chen W, Zhong Z, et al. Electroacupuncture preconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting mitophagy mediated by the mTORC1-ULK1-FUNDC1 pathway. Biomed Pharmacother. 2020;127:110148.
